trending Market Intelligence /marketintelligence/en/news-insights/trending/8Jz1TFMcQc0hsuXONdBrQQ2 content esgSubNav
In This List

Aclaris Therapeutics adds director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Aclaris Therapeutics adds director

Aclaris Therapeutics Inc. added Andrew Schiff to its board.

Schiff is a managing partner at Aisling Capital LLC.